Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regeneration in Acute Stroke
DRKS00000723Phase 2Completed
- Sponsor
- University of Regensburg
- Start
- Feb 2011
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of filgrastim in Cerebrovascular embolism and ischemic stroke (3 arms), sponsored by University of Regensburg. Started Feb 2011; status: completed.
02
Drugs
filgrastim
03
Conditions
Cerebrovascular embolismischemic stroke
Beyond the preview
Go deeper on DRKS00000723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000723.